Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Common Equity (2020 - 2025)

Historic Common Equity for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $292.3 million.

  • GeneDx Holdings' Common Equity rose 4291.27% to $292.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $292.3 million, marking a year-over-year increase of 4291.27%. This contributed to the annual value of $245.2 million for FY2024, which is 755.65% up from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Common Equity is $292.3 million, which was up 4291.27% from $277.1 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Common Equity high stood at $637.3 million for Q2 2022, and its period low was -$566.5 million during Q2 2021.
  • Its 5-year average for Common Equity is $224.1 million, with a median of $257.4 million in 2025.
  • Per our database at Business Quant, GeneDx Holdings' Common Equity soared by 772041.37% in 2021 and then crashed by 5470.15% in 2023.
  • GeneDx Holdings' Common Equity (Quarter) stood at $388.1 million in 2021, then crashed by 34.63% to $253.7 million in 2022, then fell by 10.13% to $228.0 million in 2023, then increased by 7.56% to $245.2 million in 2024, then rose by 19.17% to $292.3 million in 2025.
  • Its last three reported values are $292.3 million in Q3 2025, $277.1 million for Q2 2025, and $257.4 million during Q1 2025.